According to the 2022 World Health Organization (WHO) classification of endocrine tumours, adenohypophysial tumours, including nonfunctioning tumours, are classified based on pituitary cell lineages, which are defined by immunohistochemical (IHC) analysis of anterior pituitary hormone and pituitary‐specific transcription factor (TF) expression [1]. Here, TF is linked to neoplasm.